Health Ministry approves introduction of shorter, efficacious treatment regimen for drug-resistant… BPaLM regimen consisting of four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be…
SATB welcomes government’s decision to implement BPaLM regimen The BPaLM (Bedaquiline, Pretomanid, Linezolid and Moxifloxacin) regimen is for all patients with multi and extensively…
J&J cuts price of TB drug bedaquiline in poorer countries The move comes at a time when the virus outbreak has been feared to have derailed global efforts to curtail the spread of…
Johnson & Johnson expands efforts to help end tuberculosis in India The programme aims to broaden appropriate access to treatment for multidrug-resistant TB (MDR-TB), improve detection of…
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping… Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most…
JP Nadda launches new initiatives to combat TB Nadda also inducted over 500 Cartridge Based Nucleic Acid Amplification Test (CBNAAT) machines in the programme "The Government of…